Terminal agitation: Information for clinicians

Confusion, agitation and restlessness are common towards the end of life due to many factors, and the first question is whether there is an easily reversible cause (e.g. urinary retention). Consider all reversible causes and what treatments are still appropriate at this stage of life.

Agitation may be a sign that life is coming to an end and the best approach may be to focus on keeping the person calm. Careful discussion is needed with care givers to explore options.

Consider the following causes
  • Physical causes of discomfort including pain, nausea, constipation, urinary retention, itching due to opioids or organ failure
  • Opioid toxicity (myoclonic jerks, confusion, pin-point pupils, hallucinations and respiratory depression). If this is suspected, consider reducing the opioid by 30-50% or an opioid switch
  • Metabolic causes (hypoxia, hypercalcaemia, renal and liver failure, nicotine withdrawal)
  • Infection with delirium
  • Cerebral metastases
  • Spiritual and psychological distress
Top Tips
  • Always try non-pharmacological methods to relieve agitation e.g. presence of family, calm lighting, quiet, 1:1 care
  • Lower starting doses of sedative medication in frail elderly
  • Sedation is often more difficult if there is a history of alcohol or substance misuse
  • The intention is to relieve suffering, not to hasten death
Symptom management

The following drugs are commonly used for management of agitation at the end of life.

Haloperidol 2.5mg S/C Stat 5mg -10mg per 24h via CSCI
Midazolam 2.5mg-5mg S/C or buccal Stat 10-60mg per 24h via CSCI
Levomepromazine 12.5-25mg S/C Stat 25-150mg per 24h via CSCI
  • Starting doses of the above medication will have a calming effect but will not necessarily sedate the patient. The initial aim of treatment is to give the lowest doses to maintain calm
  • Do contact the local specialist palliative care team for more specific advice about prescribing if escalating doses of sedation are needed
  • Agitation is one of the most difficult symptoms to manage at home and important to manage confidently as families will remember this difficult time. 
  • Prescribing anticipatory medication to have at home will also help to manage symptoms.
  • Haloperidol and Levomepromazine may help more than Midazolam if hallucinations or paranoia are present. Both are also useful as anti-emetics.

Recommended Resources

West Midland Palliative Care - Restlessness and Agitation in the Dying Phase

Published 7th October 2024

Marie Curie – Agitation – Causes and How to Manage

Published 25th November 2022

North West London ICS - Palliative and end of life care

Published 1st July 2022

Scottish Palliative Care Guidelines – Severe Uncontrolled Distress

Published 22nd April 2020

CNWL Supporting excellent care in the last days of life at home

Published 1st April 2017

PANG Guidelines Quick Guide Agitation and Restlessness

Published 16th October 2016

PANG Guidelines Last Days – Agitation

Published 13th October 2016

Share

Downloads

Related Services

24 hour Helpline Pall24 for North Brent and Harrow
Close

24 hour Helpline Pall24 for North Brent and Harrow

T. 03000 200 224

This service was formerly known as Single Point of Access (SPA)

This is a 24 hour 7 days a week helpline providing advice for patients, families and professionals, hosted by St Luke's Hospice for residents of Harrow and North Brent.

Urgent rapid response visits can be made to patients registered with a Harrow GP

 

Harrow Community Palliative Care
Close

Harrow Community Palliative Care

T. 020 8102 6163

Harrow Community Specialist Palliative Care Team (LNWHT) provides advice and visiting to palliative care patients in Harrow.

They can be contacted Monday to Friday 8.30am to 4.30pm.

They are based at Honeypot Lane Health Centre, 839 Honeypot Lane, HA7 1AT.

Out of Hours the Pall24 Helpline can be used 3000 200 224

Referral form for clinician use only.

Community Specialist Palliative Care Referral Form V4.1 (DOCX)

Related Articles

8th October 2023

Anticipatory Prescribing: Information for clinicians

30th April 2024

Delirium: Information for clinicians

Feedback